Minimizing nocebo effect: Pragmatic approach
| Autor: | Mohammed Ali Albar, Majed Chamsi-Pasha, Hassan Chamsi-Pasha |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2017 |
| Předmět: |
medicine.medical_specialty
Nocebo Disease Review Article Placebo 03 medical and health sciences Epilepsy 0302 clinical medicine medicine 030212 general & internal medicine Adverse effect Psychiatry Depression (differential diagnoses) treatment business.industry Drugs medicine.disease nocebo Nocebo Effect Migraine medical ethics placebo Medicine business 030217 neurology & neurosurgery |
| Zdroj: | Avicenna Journal of Medicine Avicenna Journal of Medicine, Vol 07, Iss 04, Pp 139-143 (2017) |
| ISSN: | 2249-4464 2231-0770 |
| Popis: | The nocebo effect, the inverse of the placebo effect, is a well-established phenomenon, yet under-appreciated. It refers to nonpharmacological, harmful, or undesirable effects occurring after active or inactive therapy. The frequency of adverse events can dramatically increase by informing patients about the possible side effects of the treatment, and by negative expectations on the part of the patient. Patients who were told that they might experience sexual side effects after treatment with β-blocker drugs reported these symptoms between three and four times more often than patients in a control group who were not informed about these symptoms. Nocebo effect has been reported in several neurological diseases such as migraine, epilepsy, multiple sclerosis, Parkinson's disease and neuropathic pain, and in patients with depression. The investigation of the biological and theoretical underpinning of the nocebo phenomenon is at an early stage, and more research is required. Physicians need to be aware of the influence of nocebo phenomenon and be able to recognize it and minimize its effects. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|